Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Group 1 - Vericel Corporation is a leader in advanced therapies for sports medicine and severe burn care markets [2] - The company will have a presentation at the Canaccord Genuity Growth Conference on August 14, 2024, at 3:00 p.m. ET [1] - A webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website [1] Group 2 - Vericel markets three main products in the United States: MACI®, Epicel®, and holds an exclusive license for NexoBrid® [2] - MACI® is indicated for the repair of full-thickness cartilage defects of the knee in adults [2] - Epicel® serves as a permanent skin replacement for patients with significant burns [2] - NexoBrid® is indicated for the removal of eschar in adults with deep partial-thickness and/or full-thickness burns [2]